Table 1 The format of the analyzed drug.
From: Identification association of drug-disease by using functional gene module for breast cancer
NSC | LCONC | PANEL | CELL | NLOGGI50 | Compound | CAS |
|---|---|---|---|---|---|---|
740 | -5 | Renal | 786-0 | 7.644 | methotrexate | 1959-5-2 |
740 | -5 | Renal | A498 | 5 | methotrexate | 1959-5-2 |
740 | -8.6 | Non-Small Cell Lung | A549-ATCC | 8.602 | methotrexate | 1959-5-2 |
740 | -3.6 | Renal | ACHN | 7.308 | methotrexate | 1959-5-2 |
740 | -3.6 | Breast | BT-549 | 4.651 | methotrexate | 1959-5-2 |
740 | -3.6 | Renal | CAKI-1 | 7.124 | methotrexate | 1959-5-2 |
740 | -3.6 | Leukemia | CCRF-CEM | 7.508 | methotrexate | 1959-5-2 |
740 | -8.6 | Colon | COLO 205 | 8.602 | methotrexate | 1959-5-2 |
740 | -5 | Prostate | DU-145 | 7.238 | methotrexate | 1959-5-2 |
740 | -8.6 | Non-Small Cell Lung | EKVX | 8.602 | methotrexate | 1959-5-2 |
740 | -5 | Colon | HCC-2998 | 7.025 | methotrexate | 1959-5-2 |
740 | -8.6 | Colon | HCT-116 | 8.89 | methotrexate | 1959-5-2 |